Literature DB >> 36214865

Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.

Hardeep Singh Tuli1, Vivek Kumar Garg2, Ajay Kumar3, Diwakar Aggarwal4, Uttpal Anand5, Nidarshana Chaturvedi Parashar4, Adesh K Saini4, Ranjan K Mohapatra6, Kuldeep Dhama7, Manoj Kumar8, Tejveer Singh9, Jagjit Kaur10, Katrin Sak11.   

Abstract

Oroxylin A (OA), a well-known constituent of the root of Scutellariae plants, has been used in ethnomedicine already for centuries in treating various neoplastic disorders. However, only recent molecular studies have revealed the different mechanisms behind its action, demonstrating antiproliferative, anti-inflammatory, and proapoptotic effects, restricting also the spread of cancer cells to distant organs. A variety of cellular targets and modulated signal transduction pathways regulated by OA have been determined in diverse cells derived from different malignant tissues. In this review article, these anticancer activities are thoroughly described, representing OA as a potential lead structure for the design of novel more potent anticancer medicines. In addition, co-effects of this natural compound with conventional anticancer agents are analyzed and the advantages provided by nanotechnological methods for more efficient application of OA are discussed. In this way, OA might represent an excellent example of using ethnopharmacological knowledge for designing modern medicines.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-inflammatory; Anti-neoplastic; Cancer; Flavonoids; Oroxylin-A

Year:  2022        PMID: 36214865     DOI: 10.1007/s00210-022-02298-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.195


  97 in total

Review 1.  A review on pro- and anti-angiogenic factors as targets of clinical intervention.

Authors:  Diane Bouïs; Yoka Kusumanto; Coby Meijer; Nanno H Mulder; Geke A P Hospers
Journal:  Pharmacol Res       Date:  2006-02       Impact factor: 7.658

2.  The cell cycle and cancer.

Authors:  K Collins; T Jacks; N P Pavletich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Simultaneous determination of ten flavonoids of crude and wine-processed Radix Scutellariae aqueous extracts in rat plasma by UPLC-ESI-MS/MS and its application to a comparative pharmacokinetic study.

Authors:  Xiao-Bing Cui; Xiao-Cui Qian; Ping Huang; Yong-Xin Zhang; Jun-Song Li; Guang-Ming Yang; Bao-Chang Cai
Journal:  Biomed Chromatogr       Date:  2014-12-26       Impact factor: 1.902

4.  Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway.

Authors:  Yao Cheng; Kai Zhao; Guojun Li; Jing Yao; Qinsheng Dai; Hui Hui; Zhiyu Li; Qinglong Guo; Na Lu
Journal:  Anticancer Drugs       Date:  2014-08       Impact factor: 2.248

5.  Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress.

Authors:  Mianli Bian; Jianlin He; Huanhuan Jin; Naqi Lian; Jiangjuan Shao; Qinglong Guo; Shijun Wang; Feng Zhang; Shizhong Zheng
Journal:  Apoptosis       Date:  2019-12       Impact factor: 4.677

Review 6.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

Review 7.  Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives - A review.

Authors:  Uttpal Anand; Champa Keeya Tudu; Samapika Nandy; Kumari Sunita; Vijay Tripathi; Gary J Loake; Abhijit Dey; Jarosław Proćków
Journal:  J Ethnopharmacol       Date:  2021-10-14       Impact factor: 4.360

Review 8.  Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment.

Authors:  Meghan B Azad; Yongqiang Chen; Spencer B Gibson
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

9.  Oroxylin A, a methylated metabolite of baicalein, exhibits a stronger inhibitory effect than baicalein on the CYP1B1-mediated carcinogenic estradiol metabolite formation.

Authors:  Dongchen An; Zhongjin Song; Yingyue Yi; Qing Zhang; Jinfeng Liu; Yongjie Zhang; Jing Zhou; Guanghui Zhao; Danhua Cong; Ning Li; Yang Lu; Xijing Chen; Di Zhao
Journal:  Phytother Res       Date:  2019-01-24       Impact factor: 5.878

Review 10.  Current role of nanoparticles in the treatment of lung cancer.

Authors:  Eliseo Carrasco-Esteban; José Antonio Domínguez-Rullán; Patricia Barrionuevo-Castillo; Lira Pelari-Mici; Olwen Leaman; Sara Sastre-Gallego; Fernando López-Campos
Journal:  J Clin Transl Res       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.